EVP, Worldwide Chair Consumer Health · JOHNSON & JOHNSON (JNJ)

Thibaut Mongon

FY2022 is the first fiscal year CompBrief holds for Thibaut Mongon as a named executive officer of JOHNSON & JOHNSON; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2022

$7,092,410

Salary $917,308Stock awards $3,681,233

5th of 5 named executive officers at Johnson & Johnson by FY2022 total.

5 named officers on file for JOHNSON & JOHNSON, FY2022

Thibaut Mongon’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 3 equity grants, each cited to its filing
  • JNJ’s disclosed peer group of 17 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how JOHNSON & JOHNSON’s whole pay program stands against its peers

  • JOHNSON & JOHNSON’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on JNJ→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed March 15, 2023 (DEF 14A).

Free

Get Thibaut Mongon’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Thibaut Mongon compensation by year

JOHNSON & JOHNSON Summary Compensation Table · the one fiscal year held
In US dollars, as JOHNSON & JOHNSON reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2022
Salary$917,308
Bonus$0
Stock awards$3,681,233
Option awards$1,436,969
Non-equity incentive$798,000
Pension and deferred compensation$62,000
All other$196,900
Total$7,092,410

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: JOHNSON & JOHNSON DEF 14A filed March 15, 2023, accession 0000200406-23-000023, and prior-year filings. Open the filing on EDGAR.

How this page was built: the JOHNSON & JOHNSON filed document, accession 0000200406-23-000023. Every figure is read from that document and cited to the page and table it appears in. Filed March 15, 2023.

Equity holdings

unvested awards at FY2022 year-end
TypeUnvested unitsValue at year-endExercise price
PSU23,777$4,200,207—
PSU23,219$4,101,636—
RSU13,710$2,421,872—
RSU3,163$558,744—
RSU3,131$553,091—
RSU2,285$403,645—
Option58,447—$151.41
Option69,470—$164.62
Option61,849—$165.89

Per the Outstanding Equity Awards at Fiscal Year-End table in JOHNSON & JOHNSON's FY2022 proxy; value at the fiscal year-end close, as the company printed it.

JOHNSON & JOHNSON’s named executive officers, FY2022

as the company reported each
Named executive officerRoleFY2022 total
Joaquin DuatoChairman & Chief Executive Officer$13,099,487
Joseph WolkExecutive Vice President, Chief Financial Officer$8,823,082
Jennifer TaubertEVP, Worldwide Chair Pharmaceuticals$8,781,532
Ashley McEvoyExecutive Vice President, Worldwide Chairman, MedTech$7,390,161
Thibaut Mongon · this pageEVP, Worldwide Chair Consumer Health$7,092,410

The full JOHNSON & JOHNSON compensation record

free company brief

This page is one person within JOHNSON & JOHNSON's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the JOHNSON & JOHNSON proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are JOHNSON & JOHNSON's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Thibaut Mongon's compensation dossier · One-time report. No refunds.